Cincinnati Edition: COVID 'long haulers' face symptoms months after contracting virus
UC cardiologist says many who recover will continue to have some long-term symptoms
WVXU reporter Michael Monks spoke with Northside resident Christine Wilson who continues to recover from the effects of COVID-19 almost six months after her first diagnosis. She relies on oxygen and steroids and finds she has to budget her energy and ability to interact. Wilson says she able to do 10 minutes of activity for basically every hour of work. She is one of thousands of people across the country who continue to experience lingering symptoms after contracting COVID-19.
Richard Becker, MD, director of the UC Heart, Lung and Vascular Institute, also spoke with WVXU for the segment about his interaction with former COVID patients who are still battling health ailments related to fighting off the pandemic. Becker said worldwide there are 80 million known cases of COVID-19 and 1.7 million who died as a result. That means more than 78 million people have survived infection including 600,000 in the state of Ohio. Becker says 70 percent of individuals under age 50 and suffering from COVID-19 and without pre-existing condition such as high blood pressure, heart disease or diabetes will continue to have symptoms four to five months after their initial symptoms.
Listen to the full WVXU interview online (Richard Becker, MD, begins 14:30 minutes into the segment).
Impact Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
WLWT: Tips to fight off bad allergy symptoms
April 18, 2024
The University of Cincinnati's Ahmad Sedaghat spoke with WLWT about how Cincinnati's geography tends to make allergy symptoms worse and tips to fight off those symptoms.
Medscape: Skin adverse events rare after immunotherapy to treat...
April 17, 2024
Medscape highlighted University of Cincinnati research published in JAMA Dermatology that found skin adverse events were rare following immunotherapy treatments for certain skin cancers.
UC researchers develop new CPAP device
April 17, 2024
Researchers at the University of Cincinnati are developing a VortexPAP machine that takes advantage of vortex airflow technology. A preliminary clinical study with current CPAP users demonstrated that the VortexPAP can deliver the pressure levels that are used in the subjects’ CPAP therapy, but the mask is more comfortable to wear. It has a minimalistic design that is less intrusive and barely touches the patient’s face.